SULFAMETHOXAZOLE AND TRIMETHOPRIM Drug Patent Profile
✉ Email this page to a colleague
When do Sulfamethoxazole And Trimethoprim patents expire, and when can generic versions of Sulfamethoxazole And Trimethoprim launch?
Sulfamethoxazole And Trimethoprim is a drug marketed by Abraxis Pharm, Bedford, Hikma, Hospira, Mylan Labs Ltd, Somerset, Teva Pharms Usa, Watson Labs, Ani Pharms, Aurobindo Pharma, Chartwell Molecular, Lupin Ltd, Novitium Pharma, Prasco, Teva, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Generics, Heather, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Sun Pharm Industries, Usl Pharma, Vista Pharms, Able, and Heritage Pharma Avet. and is included in forty-seven NDAs.
The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.
Summary for SULFAMETHOXAZOLE AND TRIMETHOPRIM
US Patents: | 0 |
Applicants: | 30 |
NDAs: | 47 |
Finished Product Suppliers / Packagers: | 45 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 148 |
Patent Applications: | 3,194 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in SULFAMETHOXAZOLE AND TRIMETHOPRIM? | SULFAMETHOXAZOLE AND TRIMETHOPRIM excipients list |
DailyMed Link: | SULFAMETHOXAZOLE AND TRIMETHOPRIM at DailyMed |
Recent Clinical Trials for SULFAMETHOXAZOLE AND TRIMETHOPRIM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Early Phase 1 |
The Cleveland Clinic | Phase 4 |
Assistance Publique - Hôpitaux de Paris | Phase 4 |
Pharmacology for SULFAMETHOXAZOLE AND TRIMETHOPRIM
Anatomical Therapeutic Chemical (ATC) Classes for SULFAMETHOXAZOLE AND TRIMETHOPRIM
US Patents and Regulatory Information for SULFAMETHOXAZOLE AND TRIMETHOPRIM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 018242-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Interpharm | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 071299-001 | Oct 27, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070000-001 | Nov 7, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vista Pharms | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 076817-001 | Oct 7, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Able | SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE | phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim | TABLET;ORAL | 021105-001 | Jun 26, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roxane | SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH | sulfamethoxazole; trimethoprim | TABLET;ORAL | 072769-001 | Aug 30, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Generics | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 090828-002 | Dec 22, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |